These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Tricyclic-induced musical hallucinations and states of relative sensory deprivation. Terao T Biol Psychiatry; 1995 Aug; 38(3):192-3. PubMed ID: 7578664 [No Abstract] [Full Text] [Related]
29. Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients. Gelenberg AJ; Wojcik JD; Lydiard RB; McCormick MG; Falk WE; Hicks RH; Curren FC; Cohen BM J Clin Psychiatry; 1984 Feb; 45(2):54-56, 57-9. PubMed ID: 6363397 [TBL] [Abstract][Full Text] [Related]
30. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Bruijn JA; Moleman P; Mulder PG; van den Broek WW; van Hulst AM; van der Mast RC; van de Wetering BJ Psychopharmacology (Berl); 1996 Oct; 127(3):231-7. PubMed ID: 8912401 [TBL] [Abstract][Full Text] [Related]
31. Effect of tricyclic antidepressants on individual symptoms. Welner A; Welner Z; Robins E J Clin Psychiatry; 1980 Sep; 41(9):306-9. PubMed ID: 7410324 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and feasibility of high dose tricyclic antidepressant treatment in elderly delusional depressives. Brown RP; Kocsis JH; Glick ID; Dhar AK J Clin Psychopharmacol; 1984 Dec; 4(6):311-5. PubMed ID: 6511997 [TBL] [Abstract][Full Text] [Related]
33. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044 [TBL] [Abstract][Full Text] [Related]
34. Who benefits from tricyclic antidepressants: a survey. Goldberg SC; Tilley DH; Friedel RO; Hamer RM; Ban TA; Brockett C; Bale P; Stephens V J Clin Psychiatry; 1988 Jun; 49(6):224-8. PubMed ID: 3379027 [TBL] [Abstract][Full Text] [Related]
35. A double-blind comparative study: amineptine (Survector 100) versus imipramine. Mendis N; Hanwella DR; Weerasinghe C; Illesinghe DS; De Silva D Clin Neuropharmacol; 1989; 12 Suppl 2():S58-65. PubMed ID: 2698272 [TBL] [Abstract][Full Text] [Related]
36. Blood levels of tricyclic antidepressant drugs: assay procedures, reproducibility and relationship to therapeutic outcome and side effects. Hullin RP Postgrad Med J; 1977; 53 Suppl 4():146-54. PubMed ID: 341103 [No Abstract] [Full Text] [Related]
37. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression. Kocsis JH; Croughan JL; Katz MM; Butler TP; Secunda S; Bowden CL; Davis JM Am J Psychiatry; 1990 May; 147(5):621-4. PubMed ID: 2183635 [TBL] [Abstract][Full Text] [Related]
38. Enuresis: psychopathology, sleep stage, and drug response. Mikkelsen EJ; Rapoport JL Urol Clin North Am; 1980 Jun; 7(2):361-77. PubMed ID: 6996271 [TBL] [Abstract][Full Text] [Related]
39. [Clinical pharmacokinetics of tricyclic antidepressants. Part I. Pharmacokinetic properties]. Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A Psychiatr Pol; 1993; 27(6):683-91. PubMed ID: 8134502 [TBL] [Abstract][Full Text] [Related]
40. Tricyclic antidepressant plasma level monitoring: an improvement over the dose-response approach. Preskorn SH J Clin Psychiatry; 1986 Jan; 47(1 Suppl):24-30. PubMed ID: 2867088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]